Relationship between fasting and 2-hour postprandial plasma glucose levels and vascular complications in patients with type 2 diabetes mellitus

Journal of International Medical Research

Volumn 40, Issue 4, 2012, Pages 1295-1303

  Tanaka, M ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Brachial ankle pulse wave velocity; Coefficient of variation of r r intervals; Diabetic retinopathy; Macroangiopathy; Microangiopathy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; GLUCOSE OXIDASE; HEMOGLOBIN A1C; HYDROGEN PEROXIDE;

ADULT; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROTIC PLAQUE; B SCAN; BLOOD FLOW VELOCITY; BLOOD GLUCOSE METER; BRAIN INFARCTION; CAROTID ARTERY; CLINICAL ASSESSMENT; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; INTIMA; INTIMA MEDIA THICKNESS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; POSTPRANDIAL STATE; PULSE WAVE; THICKNESS; TUNICA MEDIA; ULTRASOUND; VASCULAR DISEASE;

EID: 84867559501     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/147323001204000408     Document Type: Article

References (22)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977 - 986.
2. Ohkubo Y, Kishikawa H, Araki E, et al: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6year study. Diabetes Res Clin Pract 1995; 28: 103 -117.
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837 - 853.
4. Stettler C, Allemann S, Jüni P, et al: Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006; 152: 27 38.
5. Ray KK, Seshasai SR, Wijesuriya S, et al: Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765 - 1772.
6. Nathan DM, Buse JB, Davidson MB: Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963 - 1972.
7. lc levels. Diabetes Res Clin Pract 2007; 77: 280 - 285.
8. Leviton EB, Song Y, Ford ES, et al: Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. Arch Intern Med 2004; 164: 2147 - 2155.
9. Hanefeld M, Cagatay M, Petrowitsch T, et al: Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Metaanalysis of seven long-term studies. Eur Heart J 2004; 25: 10 - 16.
10. Hanefeld M, Koehler C, Schaper F, et al: Postprandial plasma glucose is an independent risk factor for increased carotid intima-media thickness in non-diabetic individuals. Atheroscerosis 1999; 144: 229 - 235.
11. Sinnaeve PR, Steg PG, Fox KA, et al: Association of elevated fasting glucose with increased shortterm and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Arch Intern Med 2009; 169: 402 - 409.
12. Selvin E, Marinopoulos S, Berkenblit G, et al: Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421 - 431.
13. lc and mortality in a Japanese population. Diabetologia 2005; 48: 230 - 234.
14. Cheung N, Wang JJ, Klein R, et al: Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care 2007; 30: 1742-1746. (Pubitemid 47036346)
15. Cheung N, Rogers S, Couper DJ, et al: Is diabetic retinopathy an independent risk factor for ischemic stroke? Stroke 2007; 38: 398 - 401.
16. Klein BE, Klein R, McBride PE, et al: Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 2004; 164: 1917 1924.
17. Kramer CK, Rodrigues TC, Canani LH, et al: Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: Meta-analysis of observational studies. Diabetes Care 2011; 34: 1238 - 1244.
18. DECODE Study Group, the European Diabetes Epidemiology Group: Glucose tolerance and cardiovascular mortality: Comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397 - 405.
19. Nakagami T, Qiao Q, Tuomilehto J, et al: Screen-detected diabetes, hypertension and hypercholesterolemia as predictors of cardiovascular mortality in five populations of Asian origin: The DECODA study. Eur J Cardiovasc Prev Rehabil 2006; 13: 555 - 561.
20. Cusick M, Meleth AD, Agrón E, et al: Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: Early Treatment Diabetic Retinopathy Study report no. 27. Diabetes Care 2005;28:617-625. (Pubitemid 40315322)
21. Coppini DV, Bowtell PA, Weng C, et al: Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model. J Clin Epidemiol 2000;53:519-523. (Pubitemid 30254349)
22. Pop-Busui R, Evans GW, Gerstein HC, et al Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care 2010; 33: 1578 - 1584.